Mylan N bad news are not so bad
|By Vlad Skutelnik|
leverage ideas mylan n healthcare drug manufacturers - specialty & generic pharmaceutical products
Today's write-up is for all stakeholders who are seriously contemplating on exiting a position in Mylan N V. I will summarize the rationale of why Mylan N stakeholders should not be insulted by the new pull out. The company current daily volatility is 4.51 percent, with beta of 2.21 and alpha of -0.56 over S&P 500. Mylan N V secures last-minute Real Value of $33.8399 per share. The latest price of the firm is $21.83. At this time the firm appears to be undervalued. Macroaxis forecasts value of Mylan N V from analyzing the firm fundamentals such as Return On Equity of
1.92%, Current Valuation of 24.96B and Profit Margin of 2.14% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.
Mylan N V has 13.98B in debt with debt to equity (D/E) ratio of 117.5 . This implies that the organisation may be unable to create cash to meet all of its financial commitments. This firm dividends can provide a clue to current valuation of the stock. Mylan N is not expected to issue dividends this year as it trying to preserve or re-invest any of the funds available for distribution to stakeholders. The company has Net Profit Margin of 2.14 % which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is considered to be average in the sector. In the same way, it shows Net Operating Margin of 31.49 % which entails that for every 100 dollars of revenue it generated 0.31 of operating income.
The big decline in price over the last few months for Mylan N Vmay encourage investors to take a closer look at the firm as it closed today at a share price of 21.7568 on 3718039.000 in trading volume. The company executives failed to add value to investors and positioning the firm components to exploit market volatility in April. However, diversifying your holdings with Mylan N or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 4.51. This high volatility is attributed to the latest market swings and not so good earning reports for some of the Mylan N V partners. Mylan N discloses 117.50% in debt to equity. Mylan N is trading at 21.83. This is 9.10 percent up. Day Low was 21.7568. Mylan N Price to Book Value is decreasing over the last 5 years. The new value of Mylan N Price to Book Value is 0.99. Moreover, Mylan N Total Debt is increasing over the last 5 years. The new value of Mylan N Total Debt is 13,980,000,000.
Taking everything into account, our research shows that Mylan N is somewhat reliable with average odds of financial turmoil in the next two years. Our primary buy vs hold vs sell advice on the business is Hold.
Mylan N Debt to Cash Allocation
The company has 13.98B in debt with debt to equity (D/E) ratio of 117.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Mylan N V has Current Ratio of 1.48 which is typical for the industry and considered as normal.
Purchase by Rodney Piatt of 5000 shares of Mylan N
|Mylan N V insider trading alert for perchase of common stock by Rodney Piatt, the corporate stakeholder, on April 25, 2019. This event was filed by Mylan Nv with SEC on 2009-02-24. Statement of changes in beneficial ownership - SEC Form 4. Rodney Piatt is currently serves as vice chairman of the board, lead independent director of Mylan N V [view details]|
|Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management. View Profile|
|This article from Macroaxis published on 16 of May contributed to the next trading period closing price depreciation.The trading delta at closing time to the next next day price was 2.82% . The trading delta at closing time when the story was published to current price is 3.71% .|
Similar stores for Mylan N
Credit Capital Investments Position in Corning Cut by 450,000 as Market Value Rose Mylan NV Holder Ngam Advisors LP Has Lowered Its Holding as Stock Declined The EN HeraldCredit Capital Investments Llc decreased its stake in Corning Inc by 23.08 percent based on its latest 2018Q4 regulatory filing with the SEC. Credit Capital ...
Mylan Nv Ordinary Shares MYL Technical Update Stock Traders DailyStock in the Spotlight Mylan N.V., NewsSmoothMylan N.V. stock established at 19.64 News LeadingMylan NV Its Up In The Air But Definitely Not Out News ParentsShould You Be Concerned About This Stock Mylan N.V., NyseNewsGuruView full coverage on Google News
Cash Flow from Operations